Warning: The NCBI web site requires JavaScript to function. more...
Episodic, transient systemic acidosis delays evolution of the malignant phenotype: Possible mechanism for cancer prevention by increased physical activity.
Smallbone K, Maini PK, Gatenby RA.
Biol Direct. 2010 Apr 20;5:22.
Related citations
Metabolic changes during carcinogenesis: potential impact on invasiveness.
Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ.
J Theor Biol. 2007 Feb 21;244(4):703-13. Epub 2006 Sep 16.
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression.
Fang JS, Gillies RD, Gatenby RA.
Semin Cancer Biol. 2008 Oct;18(5):330-7. Epub 2008 Mar 26. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ.
Br J Cancer. 2007 Sep 3;97(5):646-53. Epub 2007 Aug 7.
The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA, Gawlinski ET.
Cancer Res. 2003 Jul 15;63(14):3847-54.
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL.
Gynecol Oncol. 2008 Feb;108(2):377-84. Epub 2007 Dec 4.
Why do cancers have high aerobic glycolysis?
Gatenby RA, Gillies RJ.
Nat Rev Cancer. 2004 Nov;4(11):891-9. Review.
An evolutionary model for initiation, promotion, and progression in carcinogenesis.
Vincent TL, Gatenby RA.
Int J Oncol. 2008 Apr;32(4):729-37.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
An evolutionary model of carcinogenesis.
Gatenby RA, Vincent TL.
Cancer Res. 2003 Oct 1;63(19):6212-20.
Hypoxia and adaptive landscapes in the evolution of carcinogenesis.
Gillies RJ, Gatenby RA.
Cancer Metastasis Rev. 2007 Jun;26(2):311-7. Review.
Physical activity and cancer prevention : pathways and targets for intervention.
Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD.
Sports Med. 2008;38(4):271-96. Review.
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.
Chiche J, Brahimi-Horn MC, Pouysségur J.
J Cell Mol Med. 2010 Apr;14(4):771-94. Epub 2009 Dec 8. Review.
A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.
Gerlee P, Anderson AR.
J Theor Biol. 2008 Feb 21;250(4):705-22. Epub 2007 Nov 4.
Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA, Brown PH.
Semin Oncol. 2010 Aug;37(4):345-58. Review.
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.
Mol Aspects Med. 2010 Apr;31(2):145-70. Epub 2010 Mar 2. Review.
Quiescence as a mechanism for cyclical hypoxia and acidosis.
Smallbone K, Gavaghan DJ, Maini PK, Brady JM.
J Math Biol. 2007 Nov;55(5-6):767-79. Epub 2007 Jul 3.
MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
Chen J, Miller EM, Gallo KA.
Oncogene. 2010 Aug 5;29(31):4399-411. Epub 2010 May 31.
A quantitative theoretical model for the development of malignancy in ductal carcinoma in situ.
Silva AS, Gatenby RA, Gillies RJ, Yunes JA.
J Theor Biol. 2010 Feb 21;262(4):601-13. Epub 2009 Oct 31.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on